Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects

Zhenzhou Jiang1, Meijuan Wu, Jingshan Miao

  • 1Jiangsu Center for Drug Screening, China Pharmaceutical University, Nanjing 210009, PR China.

Insights

Deoxypodophyllotoxin (DPT) shows potent anti-angiogenic and vascular disrupting effects, inhibiting tumor blood vessel formation and growth. This natural compound offers a promising strategy for novel anticancer drug development targeting tumor vasculature.

Area of Science:

  • Pharmacology
  • Cancer Biology
  • Molecular Biology

Background:

  • Tumor vascularization is crucial for solid tumor growth and metastasis.
  • Targeting tumor vasculature is a key strategy in anticancer drug discovery, employing anti-angiogenesis and vascular disruption.
  • Deoxypodophyllotoxin (DPT), a natural microtubule destabilizer, has potential anticancer properties.

Purpose of the Study:

  • To investigate the anti-angiogenic and vascular disrupting activities of deoxypodophyllotoxin (DPT).
  • To elucidate the mechanisms underlying DPT's effects on endothelial cells and tumor vasculature.

Main Methods:

  • In vitro assays: endothelial cell proliferation, migration, tube formation, capillary-like network disruption.
  • Ex vivo assays: rat aortic ring assay for angiogenesis inhibition and vascular disruption.
  • In vivo assay: chick chorioallantoic membrane assay for angiogenesis inhibition.
  • Molecular analysis: cytoskeleton reorganization, cell cycle arrest, protein expression (cyclin B1, p21), Rho/Rho kinase pathway.

Main Results:

  • DPT significantly inhibited endothelial cell proliferation, migration, and tube formation.
  • DPT demonstrated anti-angiogenic effects in rat aortic ring and chick chorioallantoic membrane assays.
  • DPT induced cytoskeleton reorganization and cell cycle arrest in endothelial cells at non-cytotoxic and higher concentrations, respectively.
  • DPT disrupted capillary-like networks in vitro and newly formed vessels in rat aortic rings, involving endothelial cell contraction via the Rho/Rho kinase pathway.

Conclusions:

  • Deoxypodophyllotoxin (DPT) exhibits significant anti-angiogenic and vascular disrupting properties.
  • DPT's mechanisms involve inhibiting endothelial cell functions, inducing cell cycle arrest, and disrupting vascular networks.
  • DPT represents a promising candidate for developing novel anticancer drugs targeting tumor vasculature.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...